Rocket Pharmaceuticals, Inc.

NASDAQ:RCKT

Biotechnology

Healthcare
$2.11 +1.84%

+$0.06 today

Market cap
$235.60M
Beta
0.47
P/E (TTM)
-1.7
EPS (TTM)
-$1.87
52W Low $2.40High $5.45

Volume 1.79M

Average 3.15M

Price history

Rocket Pharmaceuticals, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-28.23%

Period high

$5.30

Period low

$2.11

Latest

$2.11

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 12, 2026Nov 12, 2026
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
4Nov 9, 2026Nov 9, 2026
SC 13G/AOct 30, 2026Oct 30, 2026
8-KOct 6, 2026Oct 6, 2026
4Sep 15, 2026Sep 15, 2026
8-KSep 15, 2026Sep 15, 2026
25-NSESep 2, 2026Sep 2, 2026
8-KAug 27, 2026Aug 27, 2026
4Aug 20, 2026Aug 20, 2026
4Aug 20, 2026Aug 20, 2026
4Aug 17, 2026Aug 17, 2026
4Aug 17, 2026Aug 17, 2026
4Aug 13, 2026Aug 13, 2026

Competitors

Who does Rocket Pharmaceuticals, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about RCKT's filings, answered from its disclosures.

What is the latest RCKT filing?

The latest filing shown is 4 dated Nov 12, 2026.

How many recent filings does RCKT have?

Intrinsic Alpha currently shows 20 recent filings for RCKT.